Clinical Trial

MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes

Study acronym: MITO
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Stroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. Preliminary data shows a single bout of ischemic conditioning or oral ingestion of an over-the-counter antioxidant supplement called MitoQ may improve vascular function and muscle activity in individuals post-stroke.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-09.
Status change: Not Yet Recruiting → Recruiting 2025-09-22
Trial Details
NCT Number NCT06930638
Lead Sponsor Medical College of Wisconsin
Conditions Stroke
Enrollment 30 participants
Start Date 2025-07-22
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-25